Newhall Charles W III
- SEC CIK
- 0001005544
In the past year, 1 open-market sale filing worth $1.27M and no purchases.
Current role at each company
- SUPN Supernus Pharmaceuticals, Inc.Directoras of Feb 25, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.27M
- 1 filing
- Net
- −$1.27M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Newhall Charles W III as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 10, 2025 (view filing) | Oct 9 | 1 day | Newhall Charles W IIIDirector | SSale | −25.0K | $50.77 | −$1.27M | −19.3%104.6K after | 2 lots10b5-1 |
| Aug 29, 2025 (view filing) | Aug 27 | 2 days | Newhall Charles W IIIDirector | SSale | −3.59K | $45.01 | −$161.5K | −2.7%129.6K after | 10b5-1 |
| Aug 27, 2025 (view filing) | Aug 25 | 2 days | Newhall Charles W IIIDirector | SSale | −1.00K | $45.00 | −$45.0K | −0.7%133.2K after | 10b5-1 |
| Aug 26, 2025 (view filing) | Aug 22 | 4 days | Newhall Charles W IIIDirector | SSale | −1.41K | $45.00 | −$63.5K | −1.0%134.2K after | 10b5-1 |
| Nov 12, 2024 (view filing) | Nov 11 | 1 day | Newhall Charles W IIIDirector | SSale | −10.7K | $36.24 | −$387.8K | −7.6%130.3K after | |
| Nov 20, 2023 (view filing) | Nov 16 | 4 days | Newhall Charles W IIIDirector | SSale | −2.50K | $28.01 | −$70.0K | −2.1%117.1K after |